regenerative medicine | GenomeWeb

regenerative medicine

With the sequencing of the flatworm Macrostomum lignano, Cold Spring Harbor Laboratory researchers hope to provide a resource for regeneration studies.

NEW YORK (GenomeWeb News) – The Centre for Commercialization of Regenerative Medicine and Nikon has reached a deal aimed at high-throughput studies of how stem cells respond to test molecules.

The worldwide distribution agreement covers lentiviral vector technologies for induced pluripotent stem cells.

The Center for Stem Cell and Regenerative Medicine, which comprises researchers from Ohio academic institutions, research hospitals, and the private sector, will use the grant to fund nine new research projects this year and at least eight in coming years.

Tech Transfer Tidbits

Premium

Pfizer and UCL to develop stem-cell therapies for AMD; Clarient licenses breast cancer biomarkers from Indiana U; Nanosys and Harvard to outlicense nanowire IP; Luminex settles with SUNY and U of Illinois, and more …

Although iZumi does not have a license to Kyoto iPSC patents, the collaboration builds upon other seminal iPSC IP it recently licensed from Bayer. The Kyoto deal may also help the company better define iZumi's stake in what is shaping up to be a complicated IP landscape surrounding the technology.

Around the Regions

Premium

Maryland Biotechnology Investment Incentive Tax Credit, Maryland Stem Cell Research Fund, Washington State Life Sciences Discovery Fund, California Institute for Regenerative Medicine, Sanford Consortium for Regenerative Medicine, Missouri Life-Sci/Tech Tax Credits, Wisconsin Technology Venture Fund, New Jersey Edison Innovation Fund, University City Science Center QED

The deal is Salk's second broad-based research pact with a drug maker in as many years: In early 2008 the non-profit biological research institute signed a similar deal in the area of inflammation with French specialty pharma Ipsen.

Tech Transfer Tidbits

Premium

Merck Serono launches venture fund; UK's MedCell and Manchester U partner on stem cell manufacturing; VGX Pharma to study DNA vaccine tech with PATH, UPenn; and more …

Pages

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.